Search - tctmd.com

Displaying 181 - 200 of 227

Sort: Relevancy | Date

News Daily News

New Heart Failure Cases Rising Among Older Adults, MI Survivors

L.A. McKeown

November 24, 2017

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Shelley Wood

September 21, 2017

Podcast Heart Sounds

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

Ashley Lyles

July 18, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

News Daily News

Non-O Blood Types May Impart Higher Cardiovascular Risk

Todd Neale

May 02, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News ACC 2017

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

L.A. McKeown

March 09, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Conference News ESC 2016

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Shelley Wood

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

Advertisement

New Heart Failure Cases Rising Among Older Adults, MI Survivors

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Top Stories in Cardiology, August 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

TCTMD’s Top 10 Most Popular Stories for June 2017

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Non-O Blood Types May Impart Higher Cardiovascular Risk

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

N-Acetylcysteine for Myocardial Salvage in STEMI? NACIAM Trial Treads Where Many Have Flopped Before

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content